Lingli X. Dong
No. 1095 Jiefang Road
Wuhan, 430030, China
Wuhan, 430030, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 145 publications
Invasive aspergillosis in autoimmune inflammatory rheumatic diseases: epidemiology, risk factors, diagnosis, management and challenges.
Journal: Annals of medicine
Published: June 25, 2026
Obexelimab for the Treatment of IgG4-Related Disease.
Journal: The New England journal of medicine
Published: June 03, 2026
Pirfenidone combined with nintedanib in connective tissue disease - associated interstitial lung disease with radiologic progression during antifibrotic monotherapy: A case series.
Journal: Clinical rheumatology
Published: May 07, 2026
Correction: Identification and validation of necroptosis-related genes in peripheral blood mononuclear cells of Sjögren disease.
Journal: Frontiers in medicine
Published: April 07, 2026
Case Report: Secondary Osteoporosis With Extensive Bone Marrow Edema Mimicking Axial Spondyloarthritis in a Young Woman.
Journal: International journal of rheumatic diseases
Published: February 10, 2026
Targeting FcRn for immunomodulation: a promising therapy in autoimmune inflammatory rheumatic diseases.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: January 11, 2026
Anti-BCMA CAR T-cell for IgG4-related disease: is this necessary? - Authors' reply.
Journal: The Lancet. Rheumatology
Published: January 03, 2026
SSGJ-613 Alleviates Pain and Reduces the Risk of Acute Flares in Patients With Gout: A Randomized, Double-Blind, Phase II Study.
Journal: International journal of rheumatic diseases
Published: December 30, 2025
Corrigendum to "Kynurenine acts as a signaling molecule to attenuate pulmonary fibrosis by enhancing the AHR-PTEN axis" [J. Adv. Res. 71 (2025) 521-532].
Journal: Journal of advanced research
Published: December 16, 2025
Xeligekimab, an Interleukin-17A Antagonist for Active Radiographic Axial Spondyloarthritis in Chinese Patients: 16- and 48-Week Results from a Phase III, Randomized, Double-Blind, Placebo-Controlled Study.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: October 28, 2025
Myricetin Attenuates IMQ-Induced Psoriatic Inflammation Through Multi-Target Modulation: Evidence from Network Pharmacology and Experimental Validation.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 28, 2025
The role of DNASE1L3 in systemic lupus erythematosus: from pathogenesis to clinical implications.
Journal: Clinical and experimental medicine
Published: October 20, 2025
Last Updated: 09/26/2026